Virtual care platform Bright.md raised $8M in a second tranche of its Series B round, bringing its total disclosed equity funding to $21M. Its AI-led SmartExam product frees up providers by automating administrative work and remotely screening patients using its intelligent chat function.

Bright.md has offered all US hospitals free access to its Covid-19 evaluation, screening, and escalation tool. It has already screened 34K+ patients and claims to have saved 9,500+ hours for providers.